Cognitive impairment and dementia in Parkinson's disease: Clinical characteristics and treatment;Declínio cognitivo e demência associados à doença de Parkinson: Características clínicas e tratamento

Revista de Psiquiatria Clinica

Volumn 34, Issue 4, 2007, Pages 176-183

  Melo, Luciano Magalhães ^a,c   Barbosa, Egberto Reis ^a   Caramelli, Paulo ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c Universidade Federal de Minas Gerais ^*  (Brazil)

Author keywords

Cognition; Dementia; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; DONEPEZIL; GALANTAMINE; MEMANTINE; PLACEBO; RIVASTIGMINE;

BASAL GANGLION; BRAIN REGION; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; HUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

EID: 36348955137     PISSN: 01016083     EISSN: 1806938X     Source Type: Journal    
DOI: 10.1590/s0101-60832007000400003     Document Type: Review

References (82)

1. Aarsland, D.; Hutchinson, M.; Larsen, J.P. - Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia. Int J Geriatr Psychiatry 18:937-941, 2003a.
2. Aarsland, D.; Laake, K.; Larsen, J.P.; Janvin, C. - Donepezil for cognitive impairment in Parkinson'sdisease: a randomised controlled study. J Neurol Neurosurg Psychiatry 72:708-712, 2002.
3. Aarsland, D. et al. - Mental symptoms in Parkinson's disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 14:866-874, 1999.
4. Aarsland, D. et al. - Risk of dementia in Parkinson's disease: a community-based, prospective study. Neurology 56:730-736, 2001.
5. Aarsland, D. et al. - Prevalence and characteristics of dementia in Parkinson's disease: an 8-year prospective study. Arch Neurol 60:387-392, 2003b.
6. Barbosa ER, Lefèvre BH, Comerlatti LR, Scaff M, Canelas HM. - Disfunções neuropsicológicas na doença de Parkinson. Estudo de 64 casos. Arq Neuro-Psiquiatr 45:109-118, 1987.
7. Barbosa, M.T. et al. - Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil (the Bambui study). Mov Disord 21:800-808, 2006.
8. Bayles, K.A. et al. - Change in cognitive function in idiopathic Parkinson's disease. Arch Neurol 53:1140-1146, 1996.
9. Becker, T. et al. - Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 63:590-596, 1997.
10. Benke, T.H; Hohenstein, C; Poewe, W; Butterworth, B. - Repetitive speech phenomena in Parkinson's disease. Neurol. Neurosurg. Psychiatry 69: 319-324, 2000.
11. Biggins, C.A. et al. - A controlled, longitudinal study of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 55:566-571, 1992.
12. Boller, F.; Cappa, S. Cognitive deficits and dementia in Parkinson's disease. Handbook of neuropsychology. 2nd ed. Elsevier Sciences BV, Amsterdam, pp. 311-337, 2001.
13. Braak, H. et al. - Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211, 2003.
14. Bronnick, K. et al. - Neuropsychiatric disturbances in Parkinson's disease clusters in five groups with different prevalence of dementia. Acta Psychiatr Scand 112: 201-207, 2005.
15. Bullock, R.; Cameron, A. - Rivastigmine for the treatment of dementia and visual hallucinations associated with Parkinson's disease. Curr Med Res Opin 18: 258-264, 2002.
16. Burn, D.J. et al. - Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 77:585-589, 2006.
17. Caparros-Lefebvre, D. et al. - Which factors predict cognitive decline in Parkinson's disease? J Neurol Neurosurg Psychiatry 58:51-55, 1995.
18. Carbon, M.; Marie, R.M. - Functional imaging of cognition in Parkinson's disease. Curr Opin Neurol 16:475-480, 2003.
19. Cools, R.; Stefanova, E.; Barker, R.A.; Robbins, T,W.; Owen, A.M. - Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 125:584-594, 2002.
20. Corrêa, Y. Flutuação da atenção na doença de Parkinson. Tese de doutorado. Faculdade de Medicina da Universidade de São Paulo, 2006.
21. Cummings, J.L. - Intellectual impairment in Parkinson's disease: clinical, pathologic, and biochemical correlates. J Geriatr PsychiatryNeurol 1:24-36, 1988.
22. Crucian, G.P. et al. - Cognitive and vestibulo-proprioceptive components of spatial ability in Parkinson's disease. Neuropsychologia 2000;38:757-767.
23. De La Monte, S.M.; Wells, S.E.; Hedley-Whyte, E.T.; Growdon, J.H. - Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease. Ann Neurol 26:309-320, 1989.
24. De Lau, L.M.; Schipper, C.M.; Hofman, A.; Koudstaal, P.J.; Breteler, M.M. - Prognosis of Parkinson disease: risk of dementia and mortality: the Rotterdam Study. Arch Neurol 62:1265-1269, 2005.
25. Dekosky, S.T; Kaufer, D.I; Loez, O.L. - The dementias. In: Bradley GW, Daroff RB, Fenichel GM, Jankovic, J (eds.) Neurology in Clinical Practice. Vol. II. Elsevier Inc, pp. 1924-1926, 2004.
26. Emre, M. - Dementia associated with Parkinson's disease. Lancet Neurol 2: 229-237, 2003a.
27. Emre, M. - What cause mental dysfunction in Parkinson's disease? Mov Disord 18 (suppl 6): S63-S71, 2003b.
28. Emre, M. - Dementia in Parkinson's disease: cause and treatment. Curr Opin Neurol 17: 399-404, 2004.
29. Emre, M.; Aarsland, A. - Rivastigmine for dementia associated with Parkinson's disease. N Engl J Med 351: 2509-2518, 2004.
30. Folstein, M.F.; Folstein, S.E.; Mchugh, P.R. - Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198, 1975.
31. Foltynie, T.; Brayne, C.E.; Robbins, T.W.; Barker, R.A. - The cognitive ability of an incident cohort of Parkinson's patients in the UK: the CamPaIGN study. Brain 127:550-560, 2004.
32. Grossman, M.; Carvell, S.; Gollomp, S.; Stern, M.B.; Vernon, G.; Hurtig, H.I. - Sentence comprehension and praxis deficits in Parkinson's disease. Neurology 41:1620-1626, 1991.
33. Grossman, M. et al. - Information processing speed and sentence comprehension in Parkinson's disease. Neuropsychology 16: 174-181, 2002.
34. Grossman, M. et al. - Grammatical and resource components of sentence processing in Parkinson's disease - An fMRI study. Neurology 60:775-781, 2003.
35. Hayes, A.E.; Davidson, M.C.; Keele, S.W.; Rafal, R.D. Toward a functional analysis of the basal ganglia. J Cogn Neurosci 10:178-198, 1998.
36. Hobson, P.; Meara, J. - Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom. Mov Disord 19:1043-1049, 2004.
37. Holthoff-Detto, V.A. et al. - Functional effects of striatal dysfunction in Parkinson disease. Arch Neurol 54:145-150, 1997.
38. Huang, X.; Chen, P.; Kaufer, D.I.; Troster, A.I.; Poole, C. - Apolipoprotein E and dementia in Parkinson disease: a meta-analysis. Arch Neurol 63(2):189-193. 2006.
39. Hughes, T.A. et al. - A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 54:1596-1602, 2000.
40. Hurtig, H.I. et al. - Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 54:1916-1921, 2000.
41. Jacobs, D. M. et al. - Neuropsychological characteristics of preclinical dementia in Parkinson's disease. Neurology 45:1691-1696, 1995.
42. Janvin, C.; Aarsland, D.; Larsen, J.P.; Hugdahl, K. - Neuropsychological profile of patients with Parkinson's disease without dementia. Dement Geriatr Cogn Disord 15: 126-131, 2003.
43. Janvin, C.C.; Larsen, J.P.; Aarsland, D.; Hugdahl, K. - Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov Disord 23: 2006.
44. Javoy-Agid, F.; Agid, Y. - Is the mesocortical dopaminergic system involved in Parkinson's disease? Neurology 30:1326-1330, 1980.
45. Kavanagh, P.; Marder, K. - Dementia. In: Pfeiffer, R.F.; Bodis-Wollner, I. (eds.). Parkinson's disease and non motor dysfunction. Humana Press, New Jersey, pp. 35-45, 2005.
46. Klatka, L.A.; Louis, E.D.; Schiffer, R.B. - Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology 47:1148-1152, 1996.
47. Kurita, A.; Ochiai, Y.; Kono, Y.; Susuk, M.; Inoue, K. - The beneficial effect of donepezil in visual hallucinations in three patients with Parkinson's disease. J Geriatr Psychiatry Neurol 16:184-188, 2003.
48. Lang, A.e.A.M.; Lozano, A.M. - Parkinson's disease - First of two parts. N Engl J Med 339: 1044-1053, 1998.
49. Lange, K.W.; Robbins, T.W.; Marsden, C.D.; James, M.; Owen, A.M.; Paul, G.M. - L-dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction Psychopharmacology (Berl)107:394-404, 1992.
50. Lee, C.; Grossman, M.; Morris, J.; Stern, M.B.; Hurtig, H.I. - Attentional resource and processing speed limitations during sentence processing in Parkinson's disease. Brain Lang Brain Lang 85:347-356, 2003.
51. Lieberman, P.; Friedman, J.; Feldman, L.S. - Syntax comprehension in Parkinson's disease. J Nerv Ment Dis 178:360-366, 1990.
52. Litvinenko, I.V; Odinak, M.; Mogilnaya, V.I.; Shatova, A.V. - Therapy by memantine in demented patients with Parkinson's disease improves cognitive functions and preserves of motors functional abilities for 30 months period. Europ J Neurology Suppl.122:111, 2005.
53. Mahieux, F.; Michelet, D.; Manifacier, M.; Boller, F.; Fermanian, J.; Guillard, A. - Mini-mental Parkinson: first validation study of a bedside test constructed for Parkinson's disease. Behav Neurol 8: 15-22, 1995.
54. Mahieux, F. et al. - Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 64:178-183, 1998.
55. Marder, K.; Cote, L.; Tang, M. - The risk and predictive factors associated with dementia in Parkinson's disease. In: Korczyn, A. Dementia in Parkinson's disease. Monduzzi, Bologna, pp. 51-54, 1994.
56. Marder, K.; Flood, P.; Cote, L.J.; Mayeux, R. - A pilot study of risk factors for dementia in Parkinson's disease. Mov Disord 5:156-161, 1990.
57. Marder, K. et al. - The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 52:695-701, 1995.
58. Marinus, J.; Visser, M.; Verwey, N.A.; Verhey, F.R.; Middelkoop, H.A.; Stiggelbout, A.M.; van Hilten, J.J. -Assessment of cognition in Parkinson's disease. Neurology 61:1222-1228, 2003.
59. Mattila, P.M. et al. - Cortical Lewy bodies and Alzheimer-type changes in patients with Parkinson's disease. Acta Neuropathol 95:576-582, 1998.
60. Mayeux, R.; Denaro, J.; Hemenegildo, N.; Tang, M.X.; Stern, Y. - A population-based investigation of Parkinson's disease with and without dementia. Arch Neurol 49:492-497, 1992.
61. McKeith, I.G. et al. - Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65:1863-1872, 2005.
62. McNamara, P.; Durso, R.; Brown, A.; Lynch, A. - Counterfactual cognitive deficit in persons with Parkinson's disease. J Neurol Neurosurg Psychiatry 74:1065-1070, 2003.
63. Miyasak, i.J.M. et al. - Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66:996-1002, 2006.
64. Muslimovic, D. et al. - Cognitive profile of patients with newly diagnosed Parkinson disease. Neurology 65:1239-1245, 2005.
65. Oliveira, R.M.; Gurd, J.M.; Nixon, P.; Marshall, J.C.; Passingham, R.E. - Hypometria in Parkinson's disease. Automatic versus controlled processing. Move Disord 13:422-427, 1998.
66. Parkinson, J. An essay on the shaking palsy. Whittingham and Rowland for Sherwood, Neely and Jones, London, 1817.
67. Perry, E.K. et al. - Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry 48:413-421, 1985.
68. Perry, E.K. et al. - Cholinergic transmitter and neurotrophic activities in Lewy body dementia: similarity to Parkinson's and distinction from Alzheimer disease. Alzheimer Dis Assoc Disord 7:69-79, 1993.
69. Pillon, B.; Czernecki, V.; Dubois, B. - Dopamine and cognitive function. Curr Opin Neurol 16 (Suppl 2):S17-22, 2003.
70. Poewe, W.; Wolters, E.; Emre, M.; Onofrj, M.; Hsu, C.; Tekin, S.; Lane, R. - Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study. Mov Disord 2006; 21:456-461, 2006.
71. Portin, R.; Rinne, U.K. - Predictive factors for cognitive deterioration and dementia in Parkinson's disease. Adv Neurol 45:413-416, 1986.
72. Ravina, B.; Putt, M.; Siderowf, A.; Farrar, J.T.; Gillespie, M.; Crawley, A.; Fernandez, H.H.; Trieschmann, M.M.; Reichwein, S.; Simuni, T. - Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study. J Neurol Neurosurg Psychiatry 76:934-939, 2005.
73. Rinne, J.O.; Rummukainen, J.; Paljarvi, L.; Rinne, U.K. - Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 26:47-50, 1989.
74. Salganik, L.; Korczyn, A. - Risk factors for dementia in Parkinson's disease. Adv Neurol 53:343-347, 1990.
75. Schrag, A.; Jahanshahi, M.; Quinn, N. - What contributes to quality of life in patients with Parkinson's disease? J Neurol Neurosurg Psychiatry 69:308-312, 2000.
76. Thanvi, B.R.; Munshi, S.K.; Vijaykumar, N.L.o.T.C . - Neuropsychiatric non-motor aspects of Parkinson's disease. Postgrad Med J 79:561-565, 2003.
77. Uc, E.Y. et al. - Visual dysfunction in Parkinson disease without dementia. Neurology 65:1907-1913, 2005.
78. Weintraub, D.; Moberg, P.J.; Duda, J.E.; Katz, I.R.; Stern, M.B. - Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc 52:784-788, 2004.
79. Wesnes, K.A.; McKeith, I.; Edgar, C.; Emre, M.; Lane, R. - Benefits of rivastigmine on attention in dementia associated with Parkinson disease. Neurology 65:1654-1656, 2005.
80. Woods, S.P.; Troster, A.I. - Prodromal frontal/executive dysfunction predicts incident dementia in Parkinson's disease. J Int Neuropsychol Soc 9:17-24, 2003.
81. Zgaljardic, D.J.; Borod, J; Foldi, N.S.; Mattis, P. - A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry. Cog Behav Neurol 16:193-210, 2003.
82. Zweig, R.M.; Cardillo, J.E.; Cohen, M.; Giere, S.; Hedreen, J.C. - The locus ceruleus and dementia in Parkinson's disease. Neurology 43:986-991, 1993.